Physician profile
Jamie Sisk
NPI 1457489429
$1,753.40
in general payments reported to CMS, 2019-2025
20 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.07 · 2020: $117 · 2021: $263 · 2022: $428 · 2023: $305 · 2024: $242 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $414.34 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $385.30 | 2022-2025 | Nucala |
| Optinose US, INC. | $189.65 | 2021-2025 | |
| Intersect Ent, INC. | $145.52 | 2020-2022 | |
| Inspire Medical Systems, INC. | $118.52 | 2023-2025 | Inspire |
| Medtronic, INC. | $92.32 | 2021-2024 | Propel |
| Kaleo, INC. | $62.84 | 2020-2022 | |
| Acclarent, INC | $51.06 | 2021-2022 | |
| Amgen INC. | $50.89 | 2025 | Tezspire |
| Hill Dermaceuticals, INC. | $39.60 | 2024 | Tolak |
| Alk-Abello, INC | $34.82 | 2020-2022 | |
| Olympus America INC. | $31.48 | 2019-2020 | |
| Aerin Medical INC. | $28.18 | 2020-2022 | |
| Bard Access Systems, INC. | $18.62 | 2019 | |
| Uswm, LLC | $17.00 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.82 | 2025 | Tezspire |
| Hologic Sales and Service, LLC | $15.06 | 2024 | Coolseal Generator |
| Genzyme Corporation | $14.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.29 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Sisk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.